Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Halozyme Therapeutics Inc (HALO)

Healthcare Biotechnology
82.50 $
-0.9% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Halozyme Therapeutics Inc (HALO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.9% of the shares are freely tradable; institutional investors hold 107.2%.

Ownership Structure

Institutional ownership
107.2%
Insiders
1.1%
Float
98.9%
Short % of float
14.1%
Shares Outstanding
119Mio.

Largest Shareholders

Institutions

Institutions HALO
Name Stake (%) Shares Change (%) Date
BlackRock Inc 11.18 13,265,053 +0.8 03/31/2026
Vanguard Group Inc 9.75 11,566,896 -0.5 12/31/2025
Vanguard Capital Management, LLC 4.44 5,271,218 +0.0 03/31/2026
Vanguard Portfolio Management, LLC 4.43 5,249,206 +0.0 03/31/2026
State Street Corp 4.16 4,937,854 -3.6 03/31/2026
Amvescap Plc. 3.38 4,012,494 +10.0 03/31/2026
Bank of America Corp 2.46 2,913,109 +6.6 03/31/2026

Funds

Funds HALO
Name Stake (%) Shares Change (%) Date
iShares Core S&P Mid-Cap ETF 3.36 3,989,375 +0.0 05/29/2026
Vanguard Total Stock Mkt Idx Inv 3.17 3,758,680 +0.6 04/30/2026
Vanguard Small Cap Index 2.29 2,719,013 -0.2 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
8. Jul 2026 Torley Helen PRESIDENT AND CEO Sell 1,035 80.19 82,994
8. Jul 2026 Torley Helen PRESIDENT AND CEO Sell 888 79.28 70,397
8. Jul 2026 Torley Helen PRESIDENT AND CEO Other 1,923 12.07 23,211

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?